“In Silico ADME–Toxicity Profiling of 3,4-dithia-1-azabicyclo[3.2.0]heptan-7-one: Integrating Drug-Likeness, Pharmacokinetics, and Prediction Confidence” (2026) Journal of Medical and Health Sciences (JMHS), 5(1), pp. 61–80. doi:10.51317/jmhs.v5i1.1194.